BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 16596653)

  • 1. Anthropometry and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Ness RB; Allen GO
    Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term oral contraceptive use and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Am J Epidemiol; 2005 Jul; 162(1):66-72. PubMed ID: 15961588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight and body mass index and ovarian cancer risk: a case-control study in China.
    Zhang M; Xie X; Holman CD
    Gynecol Oncol; 2005 Aug; 98(2):228-34. PubMed ID: 15979697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study.
    Anderson JP; Ross JA; Folsom AR
    Cancer; 2004 Apr; 100(7):1515-21. PubMed ID: 15042687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer.
    Jeong NH; Song ES; Lee JM; Lee KB; Kim MK; Cheon JE; Lee JK; Son SK; Lee JP; Kim JH; Hur SY; Kwon YI
    Acta Obstet Gynecol Scand; 2009; 88(4):457-62. PubMed ID: 19266359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
    Risch HA; Howe GR
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
    Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk.
    Gierach GL; Modugno F; Ness RB
    Am J Epidemiol; 2005 Mar; 161(5):452-61. PubMed ID: 15718481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol, wine, and risk of epithelial ovarian cancer.
    Webb PM; Purdie DM; Bain CJ; Green AC
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):592-9. PubMed ID: 15066924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and epithelial ovarian cancer.
    Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Kato I; Koenig KL; Shore RE
    Prev Med; 2001 Dec; 33(6):682-7. PubMed ID: 11716667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender of offspring and maternal ovarian cancer risk.
    Gierach GL; Modugno F; Ness RB
    Gynecol Oncol; 2006 Jun; 101(3):476-80. PubMed ID: 16364411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of ovarian granulosa cell tumors: a case-control study.
    Boyce EA; Costaggini I; Vitonis A; Feltmate C; Muto M; Berkowitz R; Cramer D; Horowitz NS
    Gynecol Oncol; 2009 Nov; 115(2):221-5. PubMed ID: 19664811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.